Compare Stocks → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison OTCMKTS:CRRVFOTCMKTS:CTTCOTCMKTS:DXTRQOTCMKTS:RGIN Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCRRVFCVR Medical$0.00$0.00▼$0.01$30K22.35N/AN/ACTTCCalmare Therapeutics$0.00$0.00▼$0.02N/AN/AN/AN/ADXTRQDex Liquidating$0.03$0.03$0.02▼$0.16N/AN/AN/AN/ARGINRegenicin$0.01$0.00$0.00▼$0.01$829KN/A6,769 shsN/AInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRRVFCVR Medical0.00%0.00%0.00%0.00%+200.00%CTTCCalmare Therapeutics0.00%0.00%0.00%0.00%0.00%DXTRQDex Liquidating0.00%0.00%0.00%0.00%0.00%RGINRegenicin0.00%0.00%+4,900.00%+4,900.00%+233.33%“The Biggest Bubble of All Time” – Here’s What to Do. (Ad)Despite AI's incredible run-up in 2023, we're getting some conflicting messages. Analysts at JP Morgan warn that an "AI-driven bubble" could drag the entire stock market down. Folks at Morgan Stanley say AI hysteria is creating conditions like the dot-com collapse. Even AI leaders (the people who benefit the most!) are getting worried.Just click here.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCRRVFCVR MedicalN/AN/AN/AN/AN/AN/AN/AN/ACTTCCalmare TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ADXTRQDex LiquidatingN/AN/AN/AN/AN/AN/AN/AN/ARGINRegenicinN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCRRVFCVR MedicalN/AN/AN/AN/ACTTCCalmare TherapeuticsN/AN/AN/AN/ADXTRQDex LiquidatingN/AN/AN/AN/ARGINRegenicinN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCRRVFCVR MedicalN/AN/AN/AN/AN/AN/ACTTCCalmare TherapeuticsN/AN/AN/AN/AN/AN/ADXTRQDex LiquidatingN/AN/AN/AN/AN/AN/ARGINRegenicinN/AN/AN/AN/A($0.04) per shareN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCRRVFCVR Medical-$1.82MN/A0.00N/AN/AN/AN/AN/AN/ACTTCCalmare TherapeuticsN/AN/A0.00N/AN/AN/AN/AN/AN/ADXTRQDex LiquidatingN/AN/A0.00∞N/AN/AN/AN/AN/ARGINRegenicin-$640KN/A0.00∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCRRVFCVR MedicalN/AN/AN/AN/AN/ACTTCCalmare TherapeuticsN/AN/AN/AN/AN/ADXTRQDex LiquidatingN/AN/AN/AN/AN/ARGINRegenicinN/AN/AN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipCRRVFCVR MedicalN/ACTTCCalmare TherapeuticsN/ADXTRQDex LiquidatingN/ARGINRegenicin0.01%Insider OwnershipCompanyInsider OwnershipCRRVFCVR MedicalN/ACTTCCalmare Therapeutics17.50%DXTRQDex Liquidating10.43%RGINRegenicinN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCRRVFCVR MedicalN/A107.23 millionN/ANot OptionableCTTCCalmare Therapeutics7N/AN/ANot OptionableDXTRQDex LiquidatingN/AN/AN/ANot OptionableRGINRegenicin3165.77 millionN/ANot OptionableCTTC, RGIN, CRRVF, and DXTRQ HeadlinesSourceHeadlineFinancial Contrast: Sensus Healthcare (NASDAQ:SRTS) and Regenicin (OTCMKTS:RGIN)americanbankingnews.com - April 21 at 1:26 AMHistory & Traditionsmith.edu - April 20 at 11:47 PMSevere cold front hits central, eastern regions; schools forced to delay start of new semesterglobaltimes.cn - February 21 at 10:59 PMPalworld map – all locations, regions, and points of interestpcgamesn.com - February 2 at 10:38 AMAlexander boys fend off top challenger in Region 5ajc.com - January 30 at 7:33 PMJohn Kerry praises Biden for preventing 'uncontrolled war in many regions'foxnews.com - January 20 at 12:10 AMJournal of the History of Economic Thoughtcambridge.org - January 7 at 7:36 AMHistory of computers: A brief timelinelivescience.com - December 24 at 7:27 PMWATCH: Blue Origin successfully launches rocket in first flight since 2022 crashwlwt.com - December 21 at 3:37 PMBlue Origin successfully completes rocket mission more than a year after failed launchnydailynews.com - December 21 at 3:37 PMBlue Origin launches New Shepard rocket, aces landing in 1st return to flight since 2022 failure (video)space.com - December 20 at 5:23 PMJeff Bezos’ Blue Origin puts a hold on its first suborbital space launch in 15 monthsgeekwire.com - December 20 at 5:23 PMHistory of Walmart: Timeline and Factsthestreet.com - December 9 at 1:54 PMRegion police calls – Nov. 28therepublic.com - December 1 at 12:05 AMAir defenses destroy 11 Ukrainian drones over four Russian regionstass.com - November 27 at 10:05 PMNew Regions Bank coming to Kingsporttimesnews.net - November 21 at 6:09 PMFlorida high school football playoffs: A look at 5 wide open regions in the statetheledger.com - November 16 at 7:42 PMFlorida high school football playoffs: A look at the 5 deepest regions in the stategainesville.com - November 13 at 7:55 AMThe 12 Regions of China: Past and Presentthediplomat.com - October 28 at 7:48 AMVHSL power ratings | Green Run, Maury, Phoebus all lead their regions at midseasonpilotonline.com - October 6 at 11:34 PMTurtle Shells Record Nuclear Historyscientificamerican.com - September 14 at 9:47 PMDrones target six regions in largest drone attack on Russian soil since start of war in Ukrainenbcbayarea.com - September 7 at 4:29 PMNolensville Little League vs. Smithfield, Rhode Island: Little League World Series score, updatestennessean.com - September 6 at 5:21 AMRoad Trip of the Regionseducation.com - September 4 at 4:37 PMTop HeadlinesBuy the Dip in Paychex, Inc. for a Pay Check at RetirementApril 2, 2024 11:07 AMView Buy the Dip in Paychex, Inc. for a Pay Check at RetirementBuy the Dip in Netflix Stock, It Won’t Last LongApril 19, 2024 8:32 AMView Buy the Dip in Netflix Stock, It Won’t Last LongBargain Hunting: 3 Stocks With RSIs That Scream OversoldApril 19, 2024 8:59 AMView Bargain Hunting: 3 Stocks With RSIs That Scream OversoldWD-40 Company Greases the Wheels of Growth and ProfitsApril 10, 2024 10:12 AMView WD-40 Company Greases the Wheels of Growth and ProfitsWalt Disney’s Proxy Tug of War Pulls Shares to 52-Week Highs April 1, 2024 9:02 AMView Walt Disney’s Proxy Tug of War Pulls Shares to 52-Week Highs All Headlines Company DescriptionsCVR MedicalOTCMKTS:CRRVFCVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.Calmare TherapeuticsOTCMKTS:CTTCCalmare Therapeutics Incorporated, a medical device company, develops and commercializes products and technologies for chronic neuropathic pain and wound care affliction patients in the United States. Its flagship medical device is Calmare Pain Therapy Device, a non-invasive and non-addictive modality for the treatment of chronic and neuropathic pain. The company was formerly known as Competitive Technologies, Inc. and changed its name to Calmare Therapeutics Incorporated in August 2014. Calmare Therapeutics Incorporated was founded in 1968 and is based in Fairfield, Connecticut.Dex LiquidatingOTCMKTS:DXTRQDextera Surgical Inc. designs and manufactures proprietary stapling devices for surgical procedures. The company's product consists of MicroCutter 5/80 use for transection and resection in urologic, thoracic and pediatric surgical procedures, as well as application for transection, resection and/or creation of anastomoses in the intestine and the transection of the appendix. Dextera Surgical Inc., formerly known as Cardica Inc., is headquartered in Redwood City, California.RegenicinOTCMKTS:RGINRegenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.